Global Pediatric Drugs and Vaccines Market Size To Exceed USD 265.5 Billion By 2033 | CAGR of 8.04%

Global Pediatric Drugs and Vaccines Market to Exceed USD 265.5 Billion By 2033

According to a research report published by Spherical Insights & Consulting, the Global Pediatric Drugs and Vaccines Market Size is to grow from USD 122.5 Billion in 2023 to USD 265.5 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.04% during the projected period.

Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the "Global Pediatric Drugs and Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others), By Drug Indication (Infectious Disease, Cancer, Allergy and Respiratory, Nervous System Disorders, Cardiovascular Disease, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/pediatric-drugs-and-vaccines-market

Pediatrics is the field of medicine that focuses on physical, social, and mental health from birth to the end of adolescence and is widely used in pediatric therapeutic areas, including antibiotics, analgesics, respiratory, GI, and vaccinations. Drug treatment dosing in pediatrics is based on the weight or surface area of the patient's body and the patient’s age due to variations in drug absorption, distribution, metabolism, and elimination. On the other hand, pediatric vaccines aid in stimulating the immune system of pediatric patients (immunological response), thus considered as the protective shield against harmful viruses.  Pediatric drugs and vaccines are the medical supplies that are used for managing ailments/diseases in infants, children, adolescents, and young adults. The component of vaccine formulation responsible for triggering an immune response are inactive part of an antigen that produces antibodies against viruses. Vaccination has been extremely effective in preventing serious diseases and in improving health worldwide. The rising pediatric population is responsible for developing the pediatric drug and vaccine market. On the contrary, lack of accessibility due to lack of awareness and inadequate healthcare infrastructure deprives the market.   

The conjugate segment dominates the market with the largest revenue share through the forecast period.

Based on technology, the global pediatric drugs and vaccines market is segmented into live attenuated, inactivated, subunit, toxoid, conjugate, and others. Among these, the conjugate segment is dominating the market with the largest revenue share through the forecast period. The increasing demand for conjugate vaccines is due to rising cases of pneumococcal and meningococcal diseases. For instance, the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PCV23) are the two conjugate vaccines that protect against pneumococcal infections in kids.       

The infectious diseases segment is witnessing significant CAGR growth through the forecast period.

Based on the drug indication, the global pediatric drugs and vaccines market is segmented into infectious disease, cancer, allergy and respiratory, nervous system disorders, cardiovascular disease, diabetes, and others. Among these, the infectious disease segment is witnessing significant growth through the forecast period. There is growing market demand for pediatric drugs and vaccines among the common people for the infectious disease segment due to the spread of viruses like MERS, coronavirus, plague, etc.

The hospital pharmacy segment is witnessing significant CAGR growth through the forecast period.

Based on the distribution channel, the global pediatric drugs and vaccines market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacy segment is witnessing significant growth through the forecast period. Since, hospitals are the primary healthcare centers for treating pediatric ailments thus hospital pharmacy is the crucial point for accessing pediatric drugs. The collaboration of pharmaceutical companies with hospitals influences hospital pharmacies in the pediatric drug market.

North America dominates the market with the largest market share over the forecast period.

North America dominates the market with the largest market share over the forecast period. The increasing pediatric population and increasing treatment options for curing pediatric diseases uplifting the market of pediatric drugs and vaccines. In addition, the high healthcare spendings for treating pediatric diseases and accessibility of advanced pediatric ailment therapeutics due to advanced technology, and R&D of the drugs. Further, rising demand for preventive medical care and awareness regarding vaccine programs for the prevention of pediatric diseases positively influencing the pediatric drug and vaccine market in the region.

Asia-Pacific region is expected to grow the fastest during the forecast period. The increasing awareness and ease of accessibility to advanced pediatric drugs and vaccines. Further, rising disposable income and the development of healthcare infrastructure in the region lead to market growth. In addition, the rising government support and launch of new vaccines are boosting the market growth of pediatric drugs and vaccines.   

Major vendors in the global pediatric drugs and vaccines market are Novartis AG, AstraZeneca, Sanofi, GlaxoSmithKline plc., Pfizer, Merck & Co. Inc., Novo Nordisk A/S, Eli Lilly and Company, Serum Institute of India Pvt. Ltd., Panacea Biotec., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Zydus Cadila, Indian Immunologicals Ltd., Allergan Inc., and Others Key Players.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2023, FDA approved a monoclonal antibody treatment to protect infants and young babies against RSV. Nirsevimab, the antibody marketed by AstraZeneca and Sanofi as Beyfortus are one shot vaccine given to children upto 24 months of age.

• In December 2021, Novartis Cosentyx received FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis.

• In October 2021, USFDA approved innovative treatment for pediatric patients with congenital Athymia, a rare immune disorder.

• In October 2020, FDA approved first treatment for COVID-19. The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global pediatric drugs and vaccines market based on the below-mentioned segments:

Global Pediatric Drugs and Vaccines Market, Technology Analysis

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Global Pediatric Drugs and Vaccines Market, Drug Indication Analysis

• Infectious Disease
• Cancer
• Allergy and Respiratory
• Nervous System Disorders
• Cardiovascular Disease
• Diabetes
• Others

Global Pediatric Drugs and Vaccines Market, Distribution Channel Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Pediatric Drugs and Vaccines Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter